INmune Bio Stock Forecast - 20 Period Moving Average
| INMB Stock | USD 4.88 0.08 1.67% |
The 20 Period Moving Average forecasted value of INmune Bio on the next trading day is expected to be 5.47 with a mean absolute deviation of 0.46 and the sum of the absolute errors of 19.45. INmune Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast INmune Bio stock prices and determine the direction of INmune Bio's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of INmune Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
INmune |
INmune Bio 20 Period Moving Average Price Forecast For the 28th of November
Given 90 days horizon, the 20 Period Moving Average forecasted value of INmune Bio on the next trading day is expected to be 5.47 with a mean absolute deviation of 0.46, mean absolute percentage error of 0.35, and the sum of the absolute errors of 19.45.Please note that although there have been many attempts to predict INmune Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that INmune Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
INmune Bio Stock Forecast Pattern
| Backtest INmune Bio | INmune Bio Price Prediction | Buy or Sell Advice |
INmune Bio Forecasted Value
In the context of forecasting INmune Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. INmune Bio's downside and upside margins for the forecasting period are 1.09 and 9.85, respectively. We have considered INmune Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of INmune Bio stock data series using in forecasting. Note that when a statistical model is used to represent INmune Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 82.1314 |
| Bias | Arithmetic mean of the errors | 0.0536 |
| MAD | Mean absolute deviation | 0.4631 |
| MAPE | Mean absolute percentage error | 0.0863 |
| SAE | Sum of the absolute errors | 19.451 |
Predictive Modules for INmune Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as INmune Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for INmune Bio
For every potential investor in INmune, whether a beginner or expert, INmune Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. INmune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in INmune. Basic forecasting techniques help filter out the noise by identifying INmune Bio's price trends.View INmune Bio Related Equities
| Risk & Return | Correlation |
INmune Bio Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of INmune Bio's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of INmune Bio's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
INmune Bio Market Strength Events
Market strength indicators help investors to evaluate how INmune Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading INmune Bio shares will generate the highest return on investment. By undertsting and applying INmune Bio stock market strength indicators, traders can identify INmune Bio entry and exit signals to maximize returns.
| Accumulation Distribution | 6691.63 | |||
| Daily Balance Of Power | 0.32 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 4.81 | |||
| Day Typical Price | 4.83 | |||
| Price Action Indicator | 0.12 | |||
| Period Momentum Indicator | 0.08 |
INmune Bio Risk Indicators
The analysis of INmune Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in INmune Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inmune stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.28 | |||
| Standard Deviation | 4.29 | |||
| Variance | 18.41 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether INmune Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of INmune Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inmune Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inmune Bio Stock:Check out Historical Fundamental Analysis of INmune Bio to cross-verify your projections. For information on how to trade INmune Stock refer to our How to Trade INmune Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. If investors know INmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.18) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.63) | Return On Assets (0.45) | Return On Equity (0.99) |
The market value of INmune Bio is measured differently than its book value, which is the value of INmune that is recorded on the company's balance sheet. Investors also form their own opinion of INmune Bio's value that differs from its market value or its book value, called intrinsic value, which is INmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INmune Bio's market value can be influenced by many factors that don't directly affect INmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if INmune Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.